Scient Public Relations is a communications and consulting firm exclusively serving clients in the healthcare industry. Scient was founded on the principle that effective, well-executed communications strategies can help organizations achieve their business objectives and that clients are best served by senior-level communicators who have broad and deep experience in the healthcare space, who have a sophisticated understanding of the challenges and opportunities facing companies in this space, who think proactively on behalf of clients, and who deliver the highest-quality work in the most efficient manner. Services include:*Communications Planning and Program Development*Media Relations *Data Communications & Medical Meeting Support*Employee Communications / Change Management*Executive Communications / Speechwriting*Issues Management / Crisis Communications*Message Development*Presentation and Interview Preparation*Writing and Content Development*Project and Team Management

I led the Communications and Public Affairs functions, with responsibility for corporate media strategy, reputation management, executive and internal communications, community relations and philanthropy. I also oversaw legislative and regulatory strategy and policy analysis at the state and federal level.

I served as Vice President of Corporate Media Relations and Reputation Management for Wyeth, a Fortune 200 life sciences company, from April 2009 until the completion of Pfizer's acquisition of Wyeth. In this role, I was responsible for corporate media relations, issues management, corporate image and visibility. I also led all merger- and integration-related communication and internal communications company wide.

I joined Wyeth’s Corporate Affairs team in May 2007 to lead the Scientific Communications function. In this role, I was responsible for developing and implementing communications plans for the R&D organization, including several organization-wide change initiatives. I also managed scientific communications for high-priority pipeline products, including spearheading the company’s positioning efforts in Alzheimer’s disease.

In 2004, I helped launch the New Jersey office of Feinstein Kean Healthcare, a leading life-sciences communications consulting firm. At FKH, I developed and implemented public relations programs for leading pharmaceutical products and emerging technologies and played a leadership role in agency new business efforts. Clients included GlaxoSmithKline, Novartis, Pfizer and Wyeth, among others.